How AI is being used to accelerate clinical trials

How AI is being used to accelerate clinical trials

From study design to patient recruitment, researchers are investigating ways that technology could speed up the process. From study design to patient recruitment, researchers are investigating ways that technology could speed up the process.

A Roadmap For The Use Of Artificial Intelligence In Managing Trial Master Files - Data Intelligence

In a recent video interview with Applied Clinical Trials, Rob Jones, product manager, TMF practice area, Pharmalex, discussed challenges in the trial master file (TMF) space, highlighting outdated regulations such as ICH E6(R3). When it comes to innovation and compliance in the space, he stressed the importance of a risk-based approach, focusing on critical records and leveraging artificial intelligence for big data analysis. Moving forward, Jon…

EMA issues first qualification opinion for AI tool in clinical research - Fondazione Gianni Benzi Onlus

The European Medicines Agency (EMA) has issued its first Qualification Opinion (QO) on an AI-based tool for clinical research. The tool, AIM-NASH, assists pathologists in analysing liver biopsies to assess the severity of MASH (Metabolic dysfunction-associated steatohepatitis) in clinical trials. This means that the EMA’s human medicines committee (CHMP) has recognised AIM-NASH as a valid method for evaluating inflammation and fibrosis in MASH d…

Advarra announces eIRB and Study Collaboration integration for trials

Advarra has integrated its Center for IRB Intelligence (CIRBI) with the Study Collaboration for visibility into trial site activation.The post Advarra announces eIRB and Study Collaboration integration for trials appeared first on Clinical Trials Arena.